University of Pennsylvania/Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Pennsylvania/Abramson Cancer Center has participated in 203 clinical trials with 115 currently active.
Therapeutic areas: Hematopoietic and Lymphoid Cell Neoplasm, Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative.
Sponsors: Fred Hutchinson Cancer Center, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pennsylvania/Abramson Cancer Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pennsylvania/Abramson Cancer Center has 203 clinical trials on record, with 115 currently active. Their work covers Hematopoietic and Lymphoid Cell Neoplasm, Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative.
University of Pennsylvania/Abramson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.